logo
My
← Back to Magazine List

KMI Korea Medical Institute Yeouido Branch - Premier Health Examination Center in Seoul, Korea

2026. 07. 03.
KMI Korea Medical Institute Yeouido Branch is Seoul's premier preventive health examination facility, offering three distinctly differentiated personal health examination programs designed to meet diverse health assessment needs. Located in Korea's financial district with state-of-the-art imaging technology and expert medical professionals, the Yeouido facility has delivered precision diagnostics and personalized preventive care for over 30 years. This comprehensive guide compares all three examination programs, enabling informed selection based on individual health profiles, risk factors, and preventive health objectives.
01

KMI Yeouido Branch

Associated Clinics · 1

Korea Medical Institute

Seoul / Yeongdeungpo-gu

Yeouido Facility - Overview & Location

Premier Seoul Location:

Address: SK Securities Building, 24 Gukje Geumyung-ro 2-gil, Yeouido-dong, Yeongdeungpo-gu, Seoul

Strategic Location Advantages:

  • Heart of Seoul's financial and business district
  • Yeouido international business hub
  • Proximity to major corporate headquarters
  • Easy access from all Seoul regions

Transportation Access:

  • Subway: Yeouido Station (Lines 5, 9), Exits 3-4
  • Walking Distance: <2 minutes from subway exits
  • Parking: On-site and nearby facilities
  • Accessibility: Wheelchair accessible, elevator service

Facility Specifications:

  • Total Area: 2,500 pyeong (8,260 square meters)
  • Multi-Story Configuration: Comprehensive services across multiple floors
  • Modern Design: Contemporary architecture emphasizing comfort and efficiency
  • Capacity: Simultaneous multi-patient accommodation with minimal wait times

Operating Hours:

  • Weekdays: Extended hours accommodating professional schedules

Facility Amenities:

  • Spacious reception and registration areas
  • Extended waiting lounges with comfortable seating
  • Private examination rooms ensuring patient privacy
  • Refreshment services and light meal facilities
  • Recovery areas post-examination
  • Convenient restroom facilities

Advanced Medical Equipment at Yeouido

The Yeouido facility houses cutting-edge diagnostic equipment enabling superior disease detection:

Imaging Technology:

  • PET-CT: Cancer screening and neurodegeneration assessment
  • 3.0T MRI: Ultra-high resolution brain, spine, and soft tissue imaging
  • Multi-Detector CT (MDCT): Rapid, high-resolution cross-sectional imaging
  • Advanced Ultrasound: Real-time assessment of abdominal organs, thyroid, breast, and vasculature

Diagnostic Systems:

  • High-definition endoscopy for colorectal screening
  • Automated laboratory analyzers (30+ parameter comprehensive analysis)
  • Cardiac monitoring and assessment equipment
  • Pulmonary function testing systems
  • Bone density measurement (DEXA)

Colorectal Cancer Screening Center:

  • High-definition colonoscopy with therapeutic capability
  • Sleep endoscopy (sedated examination)
  • CT colonography (virtual colonoscopy alternative)
  • Specialized gastroenterology team

Three Health Examination Programs - Quick Comparison

FeaturePremium PersonalComprehensive PersonalEssential Personal
Target AudienceExecutives, High-riskProfessionals, Thorough assessmentGeneral population
Disease DetectionMaximalHighStandard
Basic Testing✓ Complete✓ Complete✓ Complete
Advanced ImagingMultiple optionsOne selectionBaseline only
Optional TestingGroups A, B, CGroup B onlyNone
Genetic ScreeningAvailable (2 panels)Not includedNot included
Preventive VaccinesAvailableNot includedNot included
Examination Duration4-5 hours3-4 hours2-3 hours
Physician ConsultationComprehensiveDetailedStandard
Recommended FrequencyAnnualBiennialBiennial
Estimated Cost RangePremiumModerateBudget-friendly

PROGRAM 1: PREMIUM PERSONAL EXAMINATION

Program Profile

Ideal For:

  • Corporate executives and C-suite professionals
  • Individuals with multiple cardiovascular risk factors
  • Strong family history of serious disease
  • Age >50 years seeking maximal preventive assessment
  • Previous abnormal screening results
  • Significant health concerns requiring advanced evaluation

Program Philosophy: Maximum disease detection capability across all organ systems with advanced genetic risk stratification and preventive intervention options.

Complete Component Breakdown

SECTION 1: PHYSICAL ASSESSMENT & VITAL SIGNS

Body Composition Analysis:

  • Height and weight measurement
  • Waist circumference assessment (metabolic risk indicator)
  • Body mass index (BMI) calculation
  • Body composition analysis (fat percentage, muscle mass, water content)
  • Metabolic rate assessment

Basic Vital Signs & Vision:

  • Blood pressure measurement
  • Visual acuity (near and distance)
  • Hearing assessment (audiometry)
  • Color vision testing
  • Fundoscopic examination (retinal evaluation)
  • Intraocular pressure measurement (glaucoma screening)

SECTION 2: CARDIAC EVALUATION

Advanced Cardiac Assessment:

  • 12-Lead Electrocardiogram (ECG): Heart rhythm, electrical activity, ischemia detection
  • Heart Rate Variability (HRV) Analysis: Autonomic nervous system function, stress assessment, cardiac risk stratification
  • Clinical significance: Early detection of cardiac abnormalities before symptom development

SECTION 3: COMPREHENSIVE LABORATORY BLOOD TESTS

Hepatic Function Panel (6 parameters):

  • Aspartate aminotransferase (AST)
  • Alanine aminotransferase (ALT)
  • Gamma-glutamyl transferase (GGT)
  • Alkaline phosphatase
  • Total and direct bilirubin

Pancreatic Function:

  • Lipase
  • Amylase

Renal Function (3 parameters):

  • Serum creatinine
  • Blood urea nitrogen (BUN)
  • Estimated glomerular filtration rate (eGFR)
  • Uric acid

Lipid Metabolism Panel (4 parameters):

  • Total cholesterol
  • Low-density lipoprotein (LDL) - "bad cholesterol"
  • High-density lipoprotein (HDL) - "good cholesterol"
  • Triglycerides

Glucose Metabolism (2 parameters):

  • Fasting blood glucose
  • Hemoglobin A1c (HbA1c) - 3-month average glucose control

Complete Blood Count (5 parameters):

  • Hemoglobin (oxygen-carrying capacity)
  • Hematocrit (red blood cell percentage)
  • White blood cell count (immune function)
  • Platelet count (clotting function)
  • Mean corpuscular volume (red cell size)

Inflammation Markers (2 parameters):

  • C-reactive protein (CRP)
  • Erythrocyte sedimentation rate (ESR)

Thyroid Function (2 parameters):

  • Thyroid-stimulating hormone (TSH)
  • Free thyroxine (Free T4)

Tumor Markers (5 parameters):

  • Alpha-fetoprotein (AFP) - hepatocellular carcinoma
  • Carcinoembryonic antigen (CEA) - colorectal cancer
  • Prostate-specific antigen (PSA) - prostate cancer
  • Cancer antigen 19-9 (CA 19-9) - pancreatic/gastric cancer
  • Cancer antigen 125 (CA 125) - ovarian cancer

Bone Metabolism (3 parameters):

  • Serum calcium
  • Serum phosphorus
  • Alkaline phosphatase
  • (Optional: Vitamin D level)

Total Laboratory Parameters: 40+ comprehensive measurements


SECTION 4: URINALYSIS

Complete Urinalysis:

  • Glucose (diabetes screening)
  • Protein (kidney disease screening)
  • Blood and red blood cells (hematuria assessment)
  • White blood cells (urinary tract infection)
  • Specific gravity (hydration status)
  • pH and crystals

SECTION 5: NEUROLOGICAL HEALTH ASSESSMENT

Alzheimer's On (Brain Health Assessment):

  • Beta-amyloid aggregation measurement
  • Preclinical Alzheimer's disease detection
  • 10-15 year early detection compared to symptomatic diagnosis
  • Enables neuroprotective intervention before cognitive decline
  • Advanced technology detecting pathology before MRI changes apparent

SECTION 6: STANDARD IMAGING STUDIES

Chest X-Ray:

  • Comprehensive pulmonary assessment
  • Cardiac silhouette evaluation
  • Mediastinal structures visualization
  • Bony thoracic cage evaluation

Abdominal Ultrasound:

  • Liver: Size, echogenicity, focal lesions, cirrhosis assessment
  • Gallbladder: Stones, polyps, wall thickness, contracted/dilated status
  • Pancreas: Size, echotexture, ductal dilatation, masses
  • Kidneys: Size, echogenicity, cysts, stones, masses
  • Spleen: Size, echotexture, focal lesions
  • Aorta: Diameter, atherosclerosis, aneurysm screening

Thyroid Ultrasound:

  • Thyroid size and echotexture
  • Nodule detection and characterization
  • Cystic versus solid lesion differentiation
  • Vascularity assessment
  • Regional lymph node evaluation

Carotid Artery Ultrasound:

  • Intima-media thickness (atherosclerosis assessment)
  • Plaque characterization
  • Stenosis degree estimation
  • Bilateral comparison
  • Stroke risk stratification

Brain MRI (Magnetic Resonance Imaging):

  • T1, T2, FLAIR sequences
  • Intracranial mass screening
  • Ischemic stroke detection
  • Hemorrhage identification
  • White matter disease assessment
  • Hippocampal atrophy (dementia risk)
  • Cerebral aneurysm detection (with MRA)

Brain MRA (Magnetic Resonance Angiography):

  • Cerebral vasculature imaging
  • Aneurysm screening
  • Arteriovenous malformation detection
  • Carotid and vertebral artery assessment
  • Stenosis degree evaluation

SECTION 7: GENDER-SPECIFIC SCREENING

For Men - Prostate Ultrasound:

  • Prostate size assessment
  • Benign prostatic hyperplasia (BPH) evaluation
  • Echotexture analysis
  • Focal lesion detection
  • Volume calculation for treatment planning
  • PSA level integration with ultrasound findings

For Women - Complete Gynecologic Screening:

  • Uterine Ultrasound: Endometrial thickness, myometrial masses, adenomyosis
  • Breast Mammography: Standard and supplemental views for breast cancer screening
  • Cervical Cancer Screening: Pap smear and HPV testing for cervical dysplasia detection

SECTION 8: OPTIONAL GROUP A (Select 1)

Choose ONE additional imaging study:

Option 1: Breast Ultrasound

  • Purpose: Complement to mammography, especially in dense breast tissue
  • Evaluation: Cystic versus solid lesion characterization
  • Advantage: No radiation, excellent tissue discrimination
  • Recommendation: Women with mammographic density, palpable masses, or family history
  • Detection Capability: Small masses <5mm visualization

Option 2: Cardiac Echocardiography

  • Purpose: Detailed cardiac structure and function assessment
  • Evaluation Parameters:
    • Left ventricular ejection fraction (LVEF) - pumping strength
    • Left ventricular mass - cardiac hypertrophy assessment
    • Diastolic function - filling abnormalities
    • Valve competency - regurgitation assessment
    • Chamber dimensions - structural abnormalities
    • Wall motion analysis - ischemia detection
  • Recommendation: Cardiac risk factors, family history, abnormal ECG, hypertension
  • Clinical Value: Identifies early cardiac dysfunction before symptom development

SECTION 9: OPTIONAL GROUP B (Select 1)

Choose ONE advanced imaging study:

Option 1: Brain CT

  • Indications: Acute neurological symptoms, trauma, rapid screening
  • Advantages: Rapid acquisition, detects acute hemorrhage, bone detail
  • Detection: Acute intracranial bleeding, mass lesions, acute ischemic stroke
  • Radiation: Moderate exposure (~2 mSv)

Option 2: Cervical Spine CT

  • Indications: Neck pain, neurological symptoms, cervical pathology assessment
  • Evaluation: Cervical vertebral alignment, disc herniation, spinal stenosis, osteophytes
  • Advantages: Superior bone detail compared to MRI
  • Radiation: Moderate exposure

Option 3: Lumbar Spine CT

  • Indications: Low back pain, radiculopathy, lumbar stenosis evaluation
  • Evaluation: Lumbar vertebral morphology, facet joint disease, stenosis degree
  • Advantages: Precise bone and joint visualization
  • Radiation: Moderate exposure

Option 4: Lung CT (High-Resolution)

  • Purpose: Early lung cancer screening in high-risk individuals
  • Detection Capability: Pulmonary nodules <1 cm visualization
  • Indications: Smoking history, significant pack-years, occupational exposure
  • Advantage: Ultra-high sensitivity for malignant nodules
  • Radiation: Low-dose protocol minimizes exposure

Option 5: Cardiac Calcium Score CT

  • Purpose: Quantifies coronary atherosclerosis burden
  • Clinical Significance: Guides preventive intervention intensity
  • Score Interpretation:
    • 0-10: No atherosclerosis
    • 11-100: Mild atherosclerosis
    • 101-400: Moderate atherosclerosis
    • 400: Severe atherosclerosis/high risk

  • Advantage: Identifies asymptomatic coronary disease
  • Radiation: Ultra-low dose (0.1 mSv)

Option 6: Abdominal Obesity CT

  • Purpose: Quantifies visceral fat distribution
  • Clinical Relevance: Visceral fat correlates with metabolic syndrome risk
  • Measurement: Precise visceral and subcutaneous fat volume (cm³)
  • Application: Metabolic risk assessment, weight management strategy
  • Advantage: Precise quantification guiding intervention

SECTION 10: OPTIONAL GROUP C (Select 2)

Choose TWO from following options:

Preventive Vaccinations:

Shingles (Herpes Zoster) Vaccination:

  • Prevention Target: Herpes zoster (shingles) and post-herpetic neuralgia
  • Recommended Age: 50+ years
  • Efficacy: 90% reduction in shingles incidence
  • Schedule: Single or two-dose regimen

Pneumococcal Disease Prevention:

  • Prevention Target: Pneumococcal bacterial infection (pneumonia, meningitis, bacteremia)
  • Recommended Age: 65+ years or chronic conditions
  • Regimen: Sequential pneumococcal conjugate and polysaccharide vaccines
  • Protection: 75-85% of disease-causing strains

Genetic Disease Screening Panels:

Genetic Eye Disease Screening (5-Gene Panel):

  1. Age-Related Macular Degeneration (AMD) Risk

    • Leading vision loss cause in elderly
    • Genetic variants increase disease susceptibility
    • Early detection enables preventive interventions
    • Vitamin supplementation can slow progression
  2. Glaucoma Susceptibility Genes

    • Progressive optic nerve damage disease
    • Genetic factors account for 60% of risk
    • Family history major risk indicator
    • Early detection prevents vision loss
  3. Keratoconus Genetic Risk

    • Progressive corneal thinning and ectasia
    • Genetic predisposition influences disease severity
    • Genetic testing guides treatment intensity
    • Contact lens intolerance assessment
  4. Severe Dry Eye Syndrome Genes

    • Significant ocular surface disease
    • Genetic factors influence tear production/quality
    • Severity assessment guides treatment selection
    • Progressive disease monitoring
  5. Retinitis Pigmentosa Genes

    • Progressive retinal dystrophy
    • Genetic mutations determine progression rate
    • Genetic counseling for family planning
    • Early intervention maximizes vision preservation

Clinical Application: Ophthalmology referral, preventive care strategies, vision preservation optimization


Genetic Dementia Screening (5-Gene Panel):

  1. Dementia Susceptibility Genes

    • General dementia risk assessment
    • Multiple genetic variants influence Alzheimer's risk
    • Early detection enables preventive strategies
    • Cognitive training, vascular risk reduction
  2. Vascular Dementia Risk Genes

    • Cerebrovascular disease-related cognitive decline
    • Hypertension, diabetes complications
    • Cardiovascular risk factor control critical
    • Stroke prevention essential
  3. Early-Onset Dementia Genes

    • Genetic forms appearing before age 65
    • APOE4 genotyping for Alzheimer's risk
    • Aggressive prevention warranted
    • Cognitive assessment baseline establishment
  4. Migraine-Dementia Association Genes

    • Migraine as potential dementia risk factor
    • Cardiovascular risk assessment
    • Preventive medication optimization
    • Lifestyle modification emphasis
  5. Depression-Cognition Relationship Genes

    • Depression associated with cognitive decline risk
    • Mental health screening and treatment critical
    • Neuroplasticity preservation emphasis
    • Psychosocial support optimization

Clinical Application: Enhanced cognitive monitoring, cardiovascular optimization, cognitive reserve enhancement, lifestyle intervention targeting, psychiatric treatment optimization


Genetic Cardiovascular Disease Screening (5-Gene Panel):

  1. Stroke Susceptibility Genes

    • Ischemic stroke predisposition assessment
    • Genetic variants influence thrombotic tendency
    • Antiplatelet/anticoagulation decision-making
    • Aggressive vascular risk reduction warranted
  2. Myocardial Infarction Risk Genes

    • Coronary artery disease susceptibility assessment
    • Genetic risk stratification guides prevention intensity
    • Lipid-lowering therapy aggressiveness
    • Early coronary imaging consideration
  3. Cerebral Aneurysm Predisposition Genes

    • Intracranial aneurysm rupture risk
    • Genetic variants increase structural weakness
    • Screening imaging consideration
    • Family history assessment critical
  4. Hypertension Genetic Markers

    • Essential hypertension susceptibility assessment
    • Salt sensitivity determination
    • Medication responsiveness prediction
    • Dietary sodium restriction guidance
  5. Type 2 Diabetes Risk Genes

    • Non-insulin-dependent diabetes susceptibility
    • Genetic variants influence insulin resistance/secretion
    • Lifestyle intervention intensity guidance
    • Pharmacologic prevention consideration

Clinical Application: Cardiovascular prevention intensity, antihypertensive/lipid-lowering therapy selection, antiplatelet therapy, lifestyle intervention targeting, specialized imaging selection


Premium Program Summary

Total Duration: 4-5 hours comprehensive examination

Basic Components: 40+ laboratory parameters + 7 imaging studies + genetic assessment

Optional Selections: 3 groups (A, B, C) enabling customization

Diagnostic Scope: Maximal disease detection across all organ systems

Risk Stratification: Advanced genetic screening enabling precision prevention

Physician Consultation: Comprehensive interpretation with prevention strategy


PROGRAM 2: COMPREHENSIVE PERSONAL EXAMINATION

Program Profile

Ideal For:

  • Professionals seeking thorough health assessment
  • Individuals with moderate health risks
  • Regular preventive health monitoring (annual/biennial)
  • Family history of specific organ disease
  • Age 40-50 seeking comprehensive baseline
  • Cost-conscious comprehensive assessment seekers

Program Philosophy: Thorough organ system evaluation combining complete basic screening with ONE strategically selected advanced imaging study, enabling efficient comprehensive assessment without multiple optional tests.

Included Components

SECTION 1: COMPLETE BASIC EXAMINATION

All components from Premium program sections 1-7:

  • Physical assessment and vital signs (11 measurements)
  • Cardiac evaluation (ECG + HRV)
  • Comprehensive laboratory blood tests (40+ parameters)
  • Neurological assessment (Alzheimer's On)
  • Urinalysis (complete analysis)
  • Standard imaging (7 studies: Chest X-ray, abdominal ultrasound, thyroid ultrasound, carotid ultrasound, Brain MRI, Brain MRA)
  • Gender-specific screening (prostate ultrasound for men; uterine ultrasound, breast mammography, cervical screening for women)

Diagnostic Coverage: All major organ systems, cancer screening, cardiovascular risk assessment, neurological evaluation


SECTION 2: OPTIONAL GROUP B (Select 1)

Choose ONE advanced imaging study:

Option 1: Brain CT

  • Recommended for: Acute neurological symptoms, rapid comprehensive assessment
  • Detects: Acute hemorrhage, masses, ischemic stroke
  • Advantage: Rapid, excellent bone detail

Option 2: Cervical Spine CT

  • Recommended for: Neck problems, neurological symptoms
  • Evaluates: Cervical pathology, stenosis, degeneration
  • Advantage: Superior bone visualization

Option 3: Lumbar Spine CT

  • Recommended for: Low back pain, radiculopathy assessment
  • Evaluates: Lumbar pathology, stenosis, disc disease
  • Advantage: Precise spinal detail

Option 4: Lung CT (High-Resolution)

  • Recommended for: Smoking history, occupational exposure risk
  • Detects: Lung nodules <1 cm, early cancer detection
  • Advantage: Ultra-high sensitivity screening

Option 5: Cardiac Calcium Score CT

  • Recommended for: Cardiovascular risk stratification
  • Quantifies: Coronary atherosclerosis burden
  • Advantage: Guides prevention intensity

Option 6: Abdominal Obesity CT

  • Recommended for: Metabolic risk assessment
  • Measures: Visceral fat distribution, metabolic risk
  • Advantage: Precise fat quantification

Comprehensive Program Summary

Total Duration: 3-4 hours examination

Basic Components: 40+ laboratory parameters + 7 imaging studies

Optional Selection: ONE study from Group B

Diagnostic Scope: High comprehensive assessment with targeted advanced imaging

Physician Consultation: Detailed interpretation and health recommendations


PROGRAM 3: ESSENTIAL PERSONAL EXAMINATION

Program Profile

Ideal For:

  • Younger individuals (20-40 years) without significant health concerns
  • Initial preventive health screening
  • Annual routine health monitoring
  • Individuals with no significant risk factors
  • Cost-conscious preventive health assessment
  • Occupational health screening requirements

Program Philosophy: Fundamental health status assessment covering all major organ systems through basic testing and standard imaging, establishing baseline health status and identifying common disease pathology.

Included Components

SECTION 1: COMPLETE BASIC EXAMINATION

All components from Premium program sections 1-7:

  • Physical assessment and vital signs (11 measurements)
  • Cardiac evaluation (ECG + HRV)
  • Comprehensive laboratory blood tests (40+ parameters)
  • Neurological assessment (Alzheimer's On)
  • Urinalysis (complete analysis)
  • Standard imaging (7 studies: Chest X-ray, abdominal ultrasound, thyroid ultrasound, carotid ultrasound, Brain MRI, Brain MRA)
  • Gender-specific screening (prostate ultrasound for men; uterine ultrasound, breast mammography, cervical screening for women)

No Additional Optional Testing


Essential Program Summary

Total Duration: 2-3 hours examination

Basic Components: 40+ laboratory parameters + 7 imaging studies

Optional Selections: None

Diagnostic Scope: Standard baseline health assessment

Physician Consultation: Standard interpretation and basic recommendations


DETAILED PROGRAM COMPARISON TABLE

Examination ComponentPremium PersonalComprehensive PersonalEssential Personal
PHYSICAL ASSESSMENT
Body composition analysis✓✓✓
Vital signs (BP, HR)✓✓✓
Vision/hearing/color vision✓✓✓
CARDIAC EVALUATION
ECG (12-lead)✓✓✓
Heart rate variability✓✓✓
LABORATORY TESTS
Liver function (6 tests)✓✓✓
Pancreatic function✓✓✓
Renal function (4 tests)✓✓✓
Lipid panel (4 tests)✓✓✓
Glucose metabolism (2 tests)✓✓✓
Complete blood count (5 tests)✓✓✓
Inflammation markers✓✓✓
Thyroid function (2 tests)✓✓✓
Tumor markers (5 tests)✓✓✓
Bone metabolism (3 tests)✓✓✓
NEUROLOGICAL
Alzheimer's On assessment✓✓✓
URINALYSIS
Complete urinalysis✓✓✓
STANDARD IMAGING (7)
Chest X-ray✓✓✓
Abdominal ultrasound✓✓✓
Thyroid ultrasound✓✓✓
Carotid ultrasound✓✓✓
Brain MRI✓✓✓
Brain MRA✓✓✓
GENDER-SPECIFIC
Prostate ultrasound (M)✓✓✓
Uterine ultrasound (W)✓✓✓
Breast mammography (W)✓✓✓
Cervical cancer screening (W)✓✓✓
OPTIONAL GROUP A
Breast ultrasound✓✗✗
Cardiac echocardiography✓✗✗
OPTIONAL GROUP B
Brain CT✓✓✗
Cervical spine CT✓✓✗
Lumbar spine CT✓✓✗
Lung CT✓✓✗
Cardiac calcium score CT✓✓✗
Abdominal obesity CT✓✓✗
OPTIONAL GROUP C
Shingles vaccination✓✗✗
Pneumococcal vaccination✓✗✗
Eye disease genetic screening✓✗✗
Dementia genetic screening✓✗✗
Cardiovascular genetic screening✓✗✗
EXAMINATION DURATION4-5 hours3-4 hours2-3 hours
LABORATORY PARAMETERS40+40+40+
IMAGING STUDIES7 + multiple options7 + 1 option7
DISEASE DETECTION SCOPEMaximalHighStandard
GENETIC SCREENINGAvailable (2 panels)Not availableNot available
PREVENTION VACCINESAvailableNot availableNot available

EXAMINATION COMPARISON BY HEALTH CONCERN

For Cancer Screening:

Cancer TypePremiumComprehensiveEssential
Lung cancerHigh-res CT optionHigh-res CT optionChest X-ray
Colorectal cancerColonoscopy optionColonoscopy optionColonoscopy option
Breast cancerMammography + USMammographyMammography
Prostate cancerPSA + ultrasoundPSA + ultrasoundPSA + ultrasound
Liver cancerAFP + ultrasoundAFP + ultrasoundAFP + ultrasound
Ovarian cancerCA-125 + ultrasoundCA-125 + ultrasoundCA-125 + ultrasound

For Cardiovascular Risk:

Cardiovascular AssessmentPremiumComprehensiveEssential
Basic ECG screening✓✓✓
Heart rate variability✓✓✓
Cardiac echocardiographyOptional (Group A)Not includedNot included
Cardiac calcium scoreOptional (Group B)Optional (Group B)Not included
Lipid panel✓✓✓
Blood pressure assessment✓✓✓
Carotid ultrasound✓✓✓
Genetic CVD screeningOptional (Group C)Not includedNot included

For Neurological Assessment:

Neurological EvaluationPremiumComprehensiveEssential
Alzheimer's On testing✓✓✓
Brain MRI✓✓✓
Brain MRA✓✓✓
Brain CTOptional (Group B)Optional (Group B)Not included
Genetic dementia screeningOptional (Group C)Not includedNot included
Cognitive assessmentIncludedIncludedIncluded

For Metabolic Assessment:

Metabolic ScreeningPremiumComprehensiveEssential
Fasting glucose✓✓✓
HbA1c (diabetes markers)✓✓✓
Lipid panel✓✓✓
Liver function tests✓✓✓
Kidney function tests✓✓✓
Abdominal ultrasound✓✓✓
Obesity CTOptional (Group B)Optional (Group B)Not included
Type 2 diabetes genetic screeningOptional (Group C)Not includedNot included

PROGRAM SELECTION GUIDANCE

Choose PREMIUM if you:

  • Hold executive/senior management position
  • Have multiple cardiovascular risk factors
  • Have strong family history of serious disease (cancer, heart disease, stroke, dementia)
  • Age >50 and seeking maximal preventive assessment
  • Have previous abnormal screening results requiring advanced evaluation
  • Experience health concerns requiring extensive diagnostic workup
  • Want most comprehensive annual/biennial health assessment
  • Seek genetic disease risk stratification
  • Can benefit from preventive vaccination programs

Choose COMPREHENSIVE if you:

  • Seek thorough health assessment without extensive optional testing
  • Have moderate health risks requiring focused evaluation
  • Prefer annual/biennial comprehensive screening
  • Have family history of specific organ disease (target CT selection accordingly)
  • Age 40-50 establishing health baseline
  • Desire balanced comprehensive/cost-effective approach
  • Want one advanced imaging study for specific concern

Choose ESSENTIAL if you:

  • Age <40 without significant health concerns
  • Establishing initial preventive health screening
  • Seeking annual routine health monitoring
  • Have no significant risk factors
  • Prefer cost-conscious preventive approach
  • Meet occupational health screening requirements
  • Want baseline health status establishment

Yeouido Facility - Convenience Features

Location Benefits:

  • Financial district central location
  • Subway-adjacent (Yeouido Station, Lines 5/9)
  • Professional district accommodations
  • Easy return-to-work capability

Time Efficiency:

  • Comprehensive services in single location
  • Efficient scheduling minimizing wait times
  • Same-day preliminary results available
  • Coordinated examination flow

Comfort Amenities:

  • 2,500 pyeong facility space
  • Private examination rooms
  • Refreshment and meal services
  • Recovery areas
  • Professional atmosphere

Patient Services:

  • Multilingual staff (English, Chinese, Japanese)
  • International patient accommodation
  • Detailed personalized health reporting
  • Physician consultation scheduling
  • Follow-up coordination

Post-Examination Services - All Programs

Comprehensive Health Report (2-3 Days):

  • Systematic findings documentation
  • Abnormality classification
  • Quantitative measurements with references
  • Radiologist interpretation
  • Physician commentary

Physician Consultation (10-14 Days):

  • Detailed findings explanation
  • Risk stratification discussion
  • Specialist referral guidance
  • Prevention strategy development
  • Follow-up timeline planning

Health Management Support:

  • Lifestyle modification counseling
  • Dietary recommendations
  • Exercise prescription
  • Stress management guidance
  • Medication optimization

Follow-Up Coordination:

  • Specialist appointment arrangement
  • Repeat examination scheduling
  • Health monitoring guidance
  • Ongoing health coaching

Contact & Appointment Information

KMI Korea Medical Institute - Yeouido Branch

Address: SK Securities Building, 24 Gukje Geumyung-ro 2-gil, Yeouido-dong, Yeongdeungpo-gu, Seoul

Subway Access: Yeouido Station (Lines 5, 9), Exits 3-4

Appointment Process:

  1. Initial contact (phone or online)
  2. Program selection consultation
  3. Flexible scheduling
  4. Pre-examination preparation
  5. Comprehensive assessment
  6. Report delivery and physician consultation

Operating Hours: Extended weekday hours, limited weekend services


Why Choose KMI Yeouido?

30+ Years Excellence: Pioneer in Korean preventive medicine with established quality leadership

Advanced Technology: PET-CT, 3.0T MRI, multi-detector CT enabling superior disease detection

Expert Medical Team: Board-certified physicians with diverse specialties and extensive preventive medicine experience

Three Comprehensive Programs: Customizable options addressing diverse health assessment needs and budgets

Premier Location: Strategic Seoul financial district with exceptional transportation access

Complete Services: Comprehensive examinations with colorectal screening center and specialized testing

Patient-Focused Care: Personalized health guidance, follow-up support, and preventive intervention coordination

International Standards: ISMS and KICS certifications ensuring information security and regulatory compliance

←Back to Magazine List